sulpiride has been researched along with risperidone in 151 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 9 (5.96) | 18.2507 |
| 2000's | 80 (52.98) | 29.6817 |
| 2010's | 59 (39.07) | 24.3611 |
| 2020's | 3 (1.99) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Chen, L; He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Wang, Y; Zhang, W | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC | 1 |
| Boriss, H; Braggio, S; Corbioli, S; Fontana, S; Helmdach, L; Longhi, R; Schiller, J; Vinco, F | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Bogdanov, MB; Gaĭnetdinov, RR; Kudrin, VS; Medvedev, OS; Val'dman, AV | 1 |
| Gerlach, J | 1 |
| Perrault, G; Sanger, DJ | 1 |
| Griffon, N; Pilon, C; Sautel, F; Schwartz, JC; Sokoloff, P | 1 |
| Hoes, MJ | 1 |
| Müssigbrodt, HE; Wetterling, T | 1 |
| Horikomi, K; Iizuka, K; Mita, N; Miwa, T; Nagase, H; Sakai, K; Sonehara, K; Takagi, K; Takahashi, S | 1 |
| Bayle, FJ; Ghaoui, S; Olie, JP | 1 |
| Bale, R; Bech, P; Fleurot, O; Möller, HJ; Peuskens, J; Rein, W | 1 |
| Möller, HJ | 2 |
| Coulouvrat, C; Dondey-Nouvel, L; Rein, W | 1 |
| Naber, D | 1 |
| McAskill, R; Taylor, DM | 1 |
| Bebbington, P; Freemantle, N; Geddes, J; Harrison, P | 1 |
| Kapur, S; Remington, G | 2 |
| Hilger, E; Kasper, S | 1 |
| Bonaccorso, S; Fowler, WL; Ichikawa, J; Ishii, H; Meltzer, HY; O'Laughlin, IA | 1 |
| Azorin, JM | 1 |
| Kruse, CG; Long, SK; Nievelstein, H; Wadman, WJ; Werkman, TR | 1 |
| Reuss, B; Unsicker, K | 1 |
| Grohmann, R; Pedrosa Gil, F; Rüther, E; Schneider, C | 1 |
| Hatzimanolis, J; Lykouras, L; Markianos, M | 1 |
| Dai, J; Fowler, WL; Ichikawa, J; Meltzer, HY; O'Laughlin, IA | 1 |
| Baptista, T | 1 |
| Bartholini, F; Casu, MA; Gessa, GL; Marchese, G; Pani, L; Ruiu, S; Saba, P | 1 |
| Miledi, R; Nguyen, QT; Yang, J | 1 |
| Bayle, FJ; Chereau, I; Lancon, C; Llorca, PM | 1 |
| Bottlender, R; Dobmeier, P; Hofschuster, E; Jäger, M; Möller, HJ | 1 |
| Möller, HJ; Peuskens, J; Puech, A | 1 |
| Jørgensen, JI; Sindø, I | 1 |
| Araujo de Baptista, E; Baptista, T; Beaulieu, S; Joober, R; Lalonde, J; Richard, D; Walker, D; Ying Kin, NM | 1 |
| Fleurot, O; Lecrubier, Y; Peuskens, J; Rein, W; Sechter, D | 1 |
| Goudie, AJ; Smith, JA | 1 |
| Danileviciūte, V | 1 |
| Chen, YS; Hwang, TJ; Lee, SM; Lee, YC; Lin, HN; Sun, HJ; Tsai, SJ | 1 |
| Castle, DJ; Lambert, TJ | 1 |
| Fric, M; Laux, G | 1 |
| Drobizhev, MIu; Kozyrev, VN; Kraeva, GK; Kubrakov, MA; Smulevich, AB | 1 |
| Bitter, I | 1 |
| Croissant, B; Heinz, A; Hermann, D; Mann, K | 1 |
| Barrett, SL; Bell, R; King, DJ; Watson, D | 1 |
| Grigor'eva, EA; Ritskov, AS | 1 |
| Bryois, Ch; Sahli, Ch | 1 |
| Lawrie, S; McIntosh, A; Nadeem, Z | 2 |
| Messer, T; Schmauss, M; Strasser, O | 1 |
| Baptista, T; Beaulieu, S; de Baptista, EA; Joober, R; Kin, NM; Lalonde, J; Plamondon, J; Richard, D | 1 |
| Barna, I; Gazdag, G; Iványi, Z; Tolna, J | 1 |
| Bressan, RA; Ell, PJ; Erlandsson, K; Pilowsky, LS; Stone, JM | 1 |
| Lawrie, S; McIntosh, A | 1 |
| Berk, M; Bourin, M; Dodd, S; Ivanovski, B; Lagopoulos, J; Malhi, GS; Mitchell, PB | 1 |
| Brown, D; Fraser, K; Martin, M; Taylor, M; Turner, M; Watt, L | 1 |
| Bastianetto, S; Danik, M; Mennicken, F; Quirion, R; Williams, S | 1 |
| Guo, WB; Guo, XF; Liu, ZN; Tang, JS; Wu, RR; Zhai, JG; Zhao, JP | 1 |
| Cipriani, A; Geddes, JR; Rendell, JM | 1 |
| Alonso, J; Haro, JM; Lépine, JP; Novick, D; Ratcliffe, M; Suarez, D | 1 |
| Ago, Y; Baba, A; Matsuda, T; Nakamura, S; Sato, M | 1 |
| Doraiswamy, PM; Edwards, R; Mueller-Oerlinghausen, B; Schott, G; Star, K | 1 |
| Lee, C; Lee, CU; Lim, HK; Pae, CU | 1 |
| Limosin, F | 1 |
| Eich, FX; Linden, M; Pyrkosch, L | 1 |
| Hui, HY; Law, WL; You, JH; Young, WM | 1 |
| Danovich, L; Gavish, M; Lahav, M; Leschiner, S; Shuster, V; Veenman, L; Weizman, A | 1 |
| Bushe, C; Shaw, M | 1 |
| Bret, MC; Bret, P; Fourier-Réglat, A; Pariente, A | 1 |
| Altunay, IK; Kayaoğlu, S; Mercan, S; Ogutcen, O; Taskintuna, N | 1 |
| Hwang, MY; Kim, JM; Kim, SW; Lee, JH; Lee, SH; Shin, IS; Yang, SJ; Yoon, BH; Yoon, JS | 1 |
| Hao, Y; Liu, H; Liu, Z; Lu, XH; Ouyang, X; Xu, L; Zuo, J | 1 |
| Cejpková, A; Rodáková, I; Svestka, J; Synek, O; Tomanová, J | 1 |
| Lawrie, SM; Shajahan, P; Taylor, M | 1 |
| Hwang, MY; Kim, JM; Kim, SW; Shin, IS; Yang, SJ; Yoon, JS | 1 |
| Barlow, KB; Kapur, S; Natesan, S; Nobrega, JN; Reckless, GE | 1 |
| Endo, S; Hamamura, T; Ishihara, T; Kuroda, S; Miyata, S; Taoka, H; Toma, K | 1 |
| Chen, CH; Lu, ML; Shen, WW | 1 |
| Eich, FX; Möller, HJ; Riedel, M | 1 |
| Ebenbichler, CF; Engl, J; Fleischhacker, WW; Kaser, S; Ott, HW; Patsch, JR; Rettenbacher, MA; Tschoner, A | 1 |
| Kumar, R; Sachdev, PS | 1 |
| Ayesa, R; Crespo-Facorro, B; Martínez-Garcia, O; Mata, I; Pérez-Iglesias, R; Ramirez-Bonilla, M; Rodríguez-Sánchez, JM; Vázquez-Barquero, JL | 1 |
| Dukić-Dejanović, S; Ignjatović, DR; Janjić, V; Jevtović, I; Jović, SD; Jurisić, V; Milovanović, DR; Pantović, MM; Ravanić, DB | 1 |
| Barbui, C; Boso, M; Cipriani, A | 1 |
| Kumar, A; Strech, D | 1 |
| Bhoopathi, PS; Hunger, H; Kissling, W; Komossa, K; Leucht, S; Rummel-Kluge, C; Schwarz, S | 1 |
| Hunger, H; Kissling, W; Komossa, K; Leucht, S; Rummel-Kluge, C; Schmid, F; Schwarz, S; Silveira da Mota Neto, JI | 1 |
| Kastania, A; Katsafouros, K; Laskos, E; Lykouras, L; Michalopoulou, PG; Papadopoulou, A; Rizos, EN; Vasilopoulos, D | 1 |
| Duggan, L; Hunger, H; Kissling, W; Komossa, K; Leucht, S; Rummel-Kluge, C; Schmid, F; Schwarz, S | 1 |
| Cicale, M; de Bartolomeis, A; Fiore, G; Iasevoli, F; Muscettola, G | 1 |
| Pavlović, E; Peitl, A; Peitl, MV; Peitl, V | 1 |
| Arakawa, R; Ito, H; Maeda, J; Okubo, Y; Okumura, M; Suhara, T; Takahashi, H; Takano, A; Takano, H | 1 |
| Araki, H; Hidaka, N; Suemaru, K | 1 |
| Davis, JM; Hunger, H; Kissling, W; Komossa, K; Leucht, S; Lobos, CA; Rummel-Kluge, C; Schmid, F; Schwarz, S | 1 |
| Claes, S; De Hert, M; Martens, GJ; Moons, T; Peuskens, J; Van Loo, KM; Van Schijndel, JE; van Winkel, R | 1 |
| Chen, J; Gao, K; Kemp, DE | 1 |
| Depping, AM; Gaudchau, A; Kissling, W; Komossa, K; Leucht, S | 1 |
| Hunger, H; Kissling, W; Komossa, K; Leucht, S; Rummel-Kluge, C; Schmid, F; Schwarz, S | 1 |
| Krishnamurthy, S; Saxena, B; Singh, S | 1 |
| Barkus, E; Craig, KJ; Dadhiwala, R; Dawson, GR; Deakin, JF; Dourish, CT; Ettinger, U; Grayson, L; Koychev, I; Lees, J; McMullen, K; Perry, C; Schmechtig, A; Walters, J; Wilkinson, L; Williams, S | 1 |
| Dudova, I; Hrdlicka, M; Urbanek, T; Zedkova, I | 1 |
| Cavanna, AE; Rickards, H; Worrall, R | 1 |
| Czernikiewicz, A; Kucharska-Pietura, K; Mortimer, A; Tylec, A | 1 |
| Chung, YC; Huang, GB; Lee, KH; Park, CH; Park, MS; Park, TW; Tong, Z; Yang, JC | 1 |
| Chang, YT; Chen, CC; Chen, WJ; Kuo, CJ; Lee, WC; Liao, YT; Shau, WY; Tsai, SY; Yang, SY | 1 |
| Chang, CH; Kao Yang, YH; Lai, EC; Lin, CY; Lin, SJ | 1 |
| Han, C; Jeong, HG; Joe, SH; Ko, YH; Lee, HY; Lee, MS | 1 |
| Dunn, G; French, P; Hutton, P; Morrison, AP; Taylor, PJ; Yung, AR | 1 |
| Ascher-Svanum, H; Bertsch, J; Brugnoli, R; Haro, JM; Hong, J; Novick, D | 1 |
| Lee, BD; Yun, HW | 1 |
| Chung, YC; Han, EH; Huang, GB; Kang, NI; Li, CR; Sui, ZY; Zhao, T | 1 |
| Chung, YC; Huang, GB; Kim, MG; Oh, KY; Park, TW; Yang, JC; Zhao, T | 1 |
| Higuchi, Y; Kawasaki, Y; Miyanishi, T; Seo, T; Sumiyoshi, T; Suzuki, M | 1 |
| Craig, KJ; Dadhiwala, R; Dawson, GR; Deakin, JF; Dourish, CT; Ettinger, U; Grayson, L; Koychev, I; Lees, J; McMullen, K; Migo, EM; Morris, R; Perry, C; Schmechtig, A; Wilkinson, L; Williams, SC | 1 |
| Cheung, C; Chua, SE; Collier, DA; Deng, W; Gong, Q; Huang, C; Jiang, L; Li, M; Li, T; Ma, X; McAlonan, GM; Sham, PC; Wang, Q; Wang, Y | 1 |
| Bhatia, MS; Jhanjee, A; Srivastava, S | 1 |
| Couchman, L; Fisher, DS; Flanagan, RJ; Handley, SA; Morgan, PE; Partridge, SJ | 1 |
| Fisher, DS; Flanagan, RJ; Handley, SA; Partridge, SJ | 1 |
| Medvedovici, A; Rădulescu, FŞ; Ranetti, AE; Voicu, V | 1 |
| Arvanitakis, P; Dimopoulou, K; Kalkavoura, CS; Lykouras, L; Michopoulos, I; Theodoropoulou, P; Tzebelikos, E | 1 |
| Bahk, WM; Wang, HR; Woo, YS | 1 |
| Cantisani, A; Ferrari, G; Grassi, G; Pallanti, S; Poli, L; Righi, L | 1 |
| Citrome, L; Czobor, P; Van Dorn, RA; Volavka, J | 1 |
| Csomor, PA; Geyer, MA; Huber, T; Preller, KH; Studerus, E; Vollenweider, FX | 1 |
| Hou, YC; Lai, CH | 1 |
| Andersen, CU; Dabrowski, K; Hansen, KB; Høimark, L; Sædder, E | 2 |
| Gillies, D; Kalakouti, E; Kyprianou, K; McLoughlin, BC; Pushpa-Rajah, JA; Rathbone, J; Variend, H | 1 |
| Cipriani, A; Davis, JM; Furukawa, TA; Goldberg, Y; Leucht, S; Levine, SZ; Samara, M; Tanaka, S | 1 |
| Amorin-Díaz, M; Aparicio-Castro, E; López-Rodríguez, E; Molina, JD; Muñoz Algar, MJ; Toledo-Romero, F | 1 |
| Chen, CY; Chen, TY; Chuang, WC; Kuo, SC; Yeh, YW | 1 |
| Chiang, HL; Hwang, TJ; Hwu, HG; Lin, YT; Shan, JC; Sheu, YH | 1 |
| Furtado, VA; Li, BG; Sampford, JR; Sampson, S; Xia, J; Zhao, S | 1 |
| Bas, A; Bas, TO; Duran, A; Emul, M; Gultekin, G; Incir, S | 1 |
| Barber, S; Cipriani, A; Corsi, M; Olotu, U | 1 |
| Hsu, CW; Lee, SY; Wang, LJ | 2 |
| Andrade, C | 1 |
| Gao, LJ; Guo, HG; Liang, ZT; Yang, Y; Zhong, XX; Zhu, JC | 1 |
| Aguirre, C; Erezuma, I; Garcia, M; Hernandez, R; Lertxundi, U; Medrano, J | 1 |
| Claro, A; Corte-Real, F; Franco, J; Monteiro, C; Mustra, C; Proença, P | 1 |
| Osman, E; Yıldız, M | 1 |
| Arani, ZM; Banafshe, HR; Ghavipanjeh, G; Heidariyeh, N; Lotfinia, M | 1 |
42 review(s) available for sulpiride and risperidone
| Article | Year |
|---|---|
New antipsychotics: classification, efficacy, and adverse effects.
Topics: Antipsychotic Agents; Basal Ganglia Diseases; Benzamides; Humans; Isoxazoles; Piperidines; Receptors, Dopamine; Receptors, Glutamate; Receptors, Neurotransmitter; Receptors, Serotonin; Remoxipride; Risperidone; Schizophrenia; Serotonin Antagonists; Sulpiride | 1991 |
Recent developments in the management of psychosis.
Topics: Antipsychotic Agents; Clozapine; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Humans; Psychotic Disorders; Risperidone; Serotonin Antagonists; Sulpiride | 1998 |
[New antipsychotic agents].
Topics: Amisulpride; Antipsychotic Agents; Benzodiazepines; Clozapine; Dibenzothiazepines; Humans; Imidazoles; Indoles; Olanzapine; Piperazines; Pirenzepine; Psychotic Disorders; Quetiapine Fumarate; Risperidone; Sulpiride; Thiazoles | 1999 |
Amisulpride: a review of its efficacy in schizophrenia.
Topics: Acute Disease; Amisulpride; Antipsychotic Agents; Brief Psychiatric Rating Scale; Chronic Disease; Clinical Trials as Topic; Flupenthixol; Haloperidol; Humans; Risperidone; Schizophrenia; Sulpiride; Treatment Outcome | 2000 |
Safety profile of amisulpride in short- and long-term use.
Topics: Amisulpride; Antipsychotic Agents; Chronic Disease; Clinical Trials as Topic; Drug Administration Schedule; Female; Haloperidol; Humans; Male; Risperidone; Schizophrenia; Sulpiride; Treatment Outcome | 2000 |
[New i.e. atypical neuroleptic agents for negative symptoms of schizophrenia: results and methodological problems of evaluation].
Topics: Amisulpride; Antipsychotic Agents; Benzodiazepines; Clozapine; Dibenzothiazepines; Dibenzothiepins; Double-Blind Method; Dyskinesia, Drug-Induced; Humans; Imidazoles; Indoles; Neurotransmitter Agents; Olanzapine; Piperazines; Pirenzepine; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia; Schizophrenic Psychology; Sulpiride; Thiazoles | 2000 |
Atypical antipsychotics and weight gain--a systematic review.
Topics: Amisulpride; Antipsychotic Agents; Benzodiazepines; Clozapine; Dibenzothiazepines; Dibenzothiepins; Humans; Imidazoles; Indoles; Olanzapine; Piperazines; Pirenzepine; Quetiapine Fumarate; Risperidone; Sulpiride; Thiazoles; Weight Gain | 2000 |
Atypical antipsychotics in the treatment of schizophrenia: systematic overview and meta-regression analysis.
Topics: Amisulpride; Antipsychotic Agents; Benzodiazepines; Clozapine; Dibenzothiazepines; Drug Costs; Humans; Imidazoles; Indoles; Olanzapine; Pirenzepine; Quetiapine Fumarate; Regression Analysis; Risperidone; Schizophrenia; Sulpiride | 2000 |
Atypical antipsychotics: new directions and new challenges in the treatment of schizophrenia.
Topics: Amisulpride; Antipsychotic Agents; Benzodiazepines; Clozapine; Dibenzothiazepines; Dibenzothiepins; Dopamine Antagonists; Drug Monitoring; Haloperidol; Humans; Imidazoles; Indoles; Olanzapine; Piperazines; Pirenzepine; Quetiapine Fumarate; Receptors, Dopamine D2; Receptors, Dopamine D4; Risperidone; Schizophrenia; Schizophrenic Psychology; Serotonin Antagonists; Sulpiride; Thiazoles; Treatment Outcome | 2001 |
[Atypical neuroleptics: new approaches to drug therapy of schizophrenic disorders].
Topics: Aged; Amisulpride; Antipsychotic Agents; Benzodiazepines; Clozapine; Controlled Clinical Trials as Topic; Dibenzothiazepines; Dibenzothiepins; Haloperidol; Humans; Imidazoles; Indoles; Multicenter Studies as Topic; Olanzapine; Piperazines; Pirenzepine; Placebos; Quetiapine Fumarate; Risperidone; Schizophrenia; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Sulpiride; Thiazoles | 2000 |
Dopamine D(2) receptors and their role in atypical antipsychotic action: still necessary and may even be sufficient.
Topics: Amisulpride; Antipsychotic Agents; Benzodiazepines; Clozapine; Dibenzothiazepines; Humans; Models, Neurological; Olanzapine; Pirenzepine; Quetiapine Fumarate; Receptors, Dopamine D2; Risperidone; Schizophrenia; Sulpiride | 2001 |
Tardive dyskinesias and antipsychotics: a review.
Topics: Amisulpride; Antipsychotic Agents; Benzodiazepines; Clozapine; Dyskinesia, Drug-Induced; Humans; Olanzapine; Pirenzepine; Prevalence; Psychotic Disorders; Risperidone; Sulpiride | 2002 |
[Treatment of tics in Tourette syndrome with atypical antipsychotic drugs].
Topics: Antipsychotic Agents; Benzodiazepines; Clozapine; Dopamine Antagonists; Humans; Olanzapine; Pirenzepine; Risperidone; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Sulpiride; Tics; Tourette Syndrome | 2002 |
[Schizoaffective disorder: clinical symptoms and present-day approach to treatment].
Topics: Adolescent; Amisulpride; Animals; Antidepressive Agents; Antidepressive Agents, Tricyclic; Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Carbamazepine; Child; Diagnosis, Differential; Dibenzothiazepines; Dogs; Female; Humans; Imidazoles; Indoles; Lithium Carbonate; Male; Mianserin; Middle Aged; Mirtazapine; Olanzapine; Piperazines; Pirenzepine; Placebos; Prognosis; Psychotic Disorders; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risperidone; Sulpiride; Thiazoles; Time Factors | 2002 |
Pharmacological approaches to the management of schizophrenia.
Topics: Amisulpride; Antipsychotic Agents; Basal Ganglia Diseases; Benzodiazepines; Clozapine; Dibenzothiazepines; Humans; Olanzapine; Pirenzepine; Quetiapine Fumarate; Risperidone; Schizophrenia; Sulpiride | 2003 |
[Current pharmacotherapy of schizophrenia].
Topics: Amisulpride; Antipsychotic Agents; Benzodiazepines; Clozapine; Dibenzothiazepines; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Risperidone; Schizophrenia; Serotonin Antagonists; Sulpiride; Thiazoles | 2004 |
[The features of atypical neuroleptic amisulpride action].
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Amisulpride; Antipsychotic Agents; Clinical Trials as Topic; Drug Interactions; Drug Therapy, Combination; Electrocardiography; Female; Haloperidol; Humans; Male; Middle Aged; Multicenter Studies as Topic; Risperidone; Schizophrenia; Sulpiride | 2004 |
[Psychotropics and weight gain].
Topics: Adolescent; Adult; Amisulpride; Antidepressive Agents; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Body Mass Index; Child; Clozapine; Dibenzothiazepines; Double-Blind Method; Female; Fructose; Haloperidol; Humans; Imidazoles; Indoles; Male; Obesity; Olanzapine; Piperazines; Placebos; Psychotropic Drugs; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Risperidone; Socioeconomic Factors; Sulpiride; Thiazoles; Time Factors; Topiramate; Valproic Acid; Weight Gain | 2004 |
Schizophrenia.
Topics: Amisulpride; Antipsychotic Agents; Benzodiazepines; Chlorpromazine; Clozapine; Cognitive Behavioral Therapy; Dibenzothiepins; Haloperidol; Humans; Olanzapine; Patient Compliance; Perazine; Pimozide; Risperidone; Schizophrenia; Sulpiride | 2003 |
Schizophrenia.
Topics: Amisulpride; Antipsychotic Agents; Benzodiazepines; Chlorpromazine; Clozapine; Haloperidol; Humans; Olanzapine; Patient Compliance; Perazine; Pimozide; Risperidone; Schizophrenia; Sulpiride | 2004 |
A typical mood stabilizers: a "typical role for atypical antipsychotics.
Topics: Affect; Amisulpride; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Clozapine; Dibenzothiazepines; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Risperidone; Secondary Prevention; Sulpiride; Thiazoles | 2005 |
Schizophrenia.
Topics: Amisulpride; Antipsychotic Agents; Chlorpromazine; Clozapine; Cognitive Behavioral Therapy; Dibenzothiepins; Family Therapy; Haloperidol; Humans; Patient Compliance; Risperidone; Schizophrenia; Secondary Prevention; Sulpiride; Thioridazine | 2005 |
Haloperidol alone or in combination for acute mania.
Topics: Amisulpride; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Carbamazepine; Dibenzothiazepines; Drug Therapy, Combination; Haloperidol; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Risperidone; Sulpiride; Valproic Acid | 2006 |
[The use of atypical antipsychotics in the long-term care of schizophrenia].
Topics: Amisulpride; Antipsychotic Agents; Aripiprazole; Basal Ganglia Diseases; Benzodiazepines; Clozapine; Cognition Disorders; Drug Tolerance; Dyskinesia, Drug-Induced; Haloperidol; Humans; Olanzapine; Piperazines; Quinolones; Risperidone; Schizophrenia; Sulpiride; Time Factors | 2006 |
Akathisia and second-generation antipsychotic drugs.
Topics: Amisulpride; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clozapine; Dibenzothiazepines; Humans; Isoxazoles; Olanzapine; Piperazines; Piperidines; Prevalence; Psychomotor Agitation; Psychotic Disorders; Quetiapine Fumarate; Quinolones; Risk Factors; Risperidone; Sulpiride; Thiazoles | 2009 |
Clozapine combined with different antipsychotic drugs for treatment resistant schizophrenia.
Topics: Amisulpride; Antipsychotic Agents; Clozapine; Dibenzothiazepines; Drug Resistance; Drug Therapy, Combination; Female; Humans; Male; Piperazines; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia; Sulpiride; Thiazoles | 2009 |
Zuclopenthixol dihydrochloride for schizophrenia.
Topics: Antipsychotic Agents; Clopenthixol; Dyskinesia, Drug-Induced; Humans; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia; Schizophrenic Psychology; Sulpiride | 2009 |
Ziprasidone versus other atypical antipsychotics for schizophrenia.
Topics: Amisulpride; Antipsychotic Agents; Benzodiazepines; Clozapine; Dibenzothiazepines; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia; Sulpiride; Thiazoles | 2009 |
Amisulpride versus other atypical antipsychotics for schizophrenia.
Topics: Amisulpride; Antipsychotic Agents; Benzodiazepines; Humans; Olanzapine; Piperazines; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia; Sulpiride; Thiazoles | 2010 |
Olanzapine versus other atypical antipsychotics for schizophrenia.
Topics: Amisulpride; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clozapine; Dibenzothiazepines; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Risperidone; Schizophrenia; Sulpiride; Thiazoles | 2010 |
Head-to-head comparisons of metabolic side effects of second generation antipsychotics in the treatment of schizophrenia: a systematic review and meta-analysis.
Topics: Amisulpride; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Blood Glucose; Cholesterol; Clinical Trials as Topic; Clozapine; Dibenzothiazepines; Humans; Imidazoles; Indoles; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Risperidone; Schizophrenia; Sulpiride; Thiazoles; Weight Gain | 2010 |
Second-generation antipsychotics in major depressive disorder: update and clinical perspective.
Topics: Adult; Amisulpride; Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Depressive Disorder, Major; Dibenzothiazepines; Drug Therapy, Combination; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Risperidone; Sulpiride | 2011 |
Second-generation antipsychotics for major depressive disorder and dysthymia.
Topics: Amisulpride; Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Depressive Disorder, Major; Dibenzothiazepines; Dysthymic Disorder; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Risperidone; Sulpiride | 2010 |
Risperidone versus other atypical antipsychotics for schizophrenia.
Topics: Amisulpride; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clozapine; Dibenzothiazepines; Humans; Imidazoles; Indoles; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia; Sulpiride; Thiazoles | 2011 |
Drug-induced hypo- and hyperprolactinemia: mechanisms, clinical and therapeutic consequences.
Topics: Amisulpride; Antipsychotic Agents; Aripiprazole; Blood-Brain Barrier; Humans; Hyperprolactinemia; Isoxazoles; Paliperidone Palmitate; Piperazines; Prolactin; Pyrimidines; Quinolones; Receptors, Dopamine D2; Risperidone; Stress, Psychological; Sulpiride; Xenobiotics | 2013 |
Atypical antipsychotics in the treatment of delirium.
Topics: Amisulpride; Antipsychotic Agents; Benzodiazepines; Delirium; Dibenzothiazepines; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risperidone; Sulpiride; Thiazoles | 2013 |
[Sparse evidence of antipsychotic drugs for the treatment of delirium].
Topics: Amisulpride; Antipsychotic Agents; Benzodiazepines; Delirium; Evidence-Based Medicine; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Risperidone; Sulpiride; Thiazoles | 2014 |
Cannabis and schizophrenia.
Topics: Amisulpride; Antipsychotic Agents; Benzodiazepines; Cannabinoids; Humans; Marijuana Abuse; Medical Marijuana; Olanzapine; Psychotherapy; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia; Sulpiride | 2014 |
[Sparse evidence of antipsychotic drugs for the treatment of delirium].
Topics: Amisulpride; Antipsychotic Agents; Benzodiazepines; Delirium; Evidence-Based Medicine; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Risperidone; Sulpiride; Thiazoles | 2014 |
Initial severity of schizophrenia and efficacy of antipsychotics: participant-level meta-analysis of 6 placebo-controlled studies.
Topics: Adult; Amisulpride; Antipsychotic Agents; Benzodiazepines; Drug Monitoring; Female; Humans; Male; Olanzapine; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia; Schizophrenic Psychology; Severity of Illness Index; Sulpiride; Treatment Outcome | 2015 |
Fluphenazine (oral) versus atypical antipsychotics for schizophrenia.
Topics: Administration, Oral; Amisulpride; Antipsychotic Agents; Benzodiazepines; Fluphenazine; Humans; Olanzapine; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia; Sulpiride; Treatment Outcome | 2016 |
Clozapine combined with different antipsychotic drugs for treatment-resistant schizophrenia.
Topics: Adult; Amisulpride; Antipsychotic Agents; Aripiprazole; Clozapine; Dibenzothiazepines; Drug Resistance; Drug Therapy, Combination; Female; Haloperidol; Humans; Male; Piperazines; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia; Sulpiride; Thiazoles; Weight Gain | 2017 |
19 trial(s) available for sulpiride and risperidone
| Article | Year |
|---|---|
New antipsychotics: classification, efficacy, and adverse effects.
Topics: Antipsychotic Agents; Basal Ganglia Diseases; Benzamides; Humans; Isoxazoles; Piperidines; Receptors, Dopamine; Receptors, Glutamate; Receptors, Neurotransmitter; Receptors, Serotonin; Remoxipride; Risperidone; Schizophrenia; Serotonin Antagonists; Sulpiride | 1991 |
Amisulpride vs. risperidone in the treatment of acute exacerbations of schizophrenia. Amisulpride study group.
Topics: Acute Disease; Adult; Amisulpride; Antipsychotic Agents; Body Weight; Double-Blind Method; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Remission Induction; Risperidone; Schizophrenia; Sulpiride; Treatment Outcome | 1999 |
Neuroendocrine responsivities of the pituitary dopamine system in male schizophrenic patients during treatment with clozapine, olanzapine, risperidone, sulpiride, or haloperidol.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Clozapine; Dopamine Antagonists; Dose-Response Relationship, Drug; Haloperidol; Humans; Male; Middle Aged; Olanzapine; Pirenzepine; Pituitary Gland; Prolactin; Receptors, Dopamine D2; Risperidone; Schizophrenia; Sulpiride | 2001 |
Amisulpride vs. risperidone in chronic schizophrenia: results of a 6-month double-blind study.
Topics: Adolescent; Adult; Aged; Amisulpride; Analysis of Variance; Chi-Square Distribution; Chronic Disease; Confidence Intervals; Double-Blind Method; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Risperidone; Schizophrenia; Single-Blind Method; Sulpiride | 2002 |
Amisulpride versus risperidone in the treatment of schizophrenic patients: a double-blind pilot study in Taiwan.
Topics: Amisulpride; Antipsychotic Agents; Double-Blind Method; Female; Humans; Male; Pilot Projects; Psychiatric Status Rating Scales; Risperidone; Schizophrenia; Statistics, Nonparametric; Sulpiride; Taiwan; Treatment Outcome | 2003 |
Non-uniform blockade of intrastriatal D2/D3 receptors by risperidone and amisulpride.
Topics: Adult; Amisulpride; Antipsychotic Agents; Benzamides; Binding, Competitive; Brain Mapping; Case-Control Studies; Corpus Striatum; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Female; Humans; Iodine Isotopes; Male; Pyrrolidines; Receptors, Dopamine D3; Risperidone; Schizophrenia; Sulpiride; Tomography, Emission-Computed, Single-Photon | 2005 |
Effects of typical and atypical antipsychotics on glucose-insulin homeostasis and lipid metabolism in first-episode schizophrenia.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Blood Glucose; Body Mass Index; C-Peptide; Cholesterol; Clozapine; Female; Homeostasis; Humans; Insulin; Insulin Resistance; Lipid Metabolism; Male; Metabolic Syndrome; Olanzapine; Prospective Studies; Risperidone; Schizophrenia; Sulpiride; Triglycerides; Waist-Hip Ratio | 2006 |
Amisulpride versus risperidone treatment for behavioral and psychological symptoms in patients with dementia of the Alzheimer type: a randomized, open, prospective study.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amisulpride; Antipsychotic Agents; Behavioral Symptoms; Female; Humans; Male; Prospective Studies; Psychiatric Status Rating Scales; Psychotic Disorders; Risperidone; Severity of Illness Index; Sulpiride; Time Factors | 2006 |
Amisulpride versus risperidone in the treatment of depression in patients with schizophrenia: a randomized, open-label, controlled trial.
Topics: Adolescent; Adult; Amisulpride; Antipsychotic Agents; Depressive Disorder; Electrocardiography; Endpoint Determination; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Risperidone; Schizophrenia; Sulpiride | 2007 |
Differences in the effect of second-generation antipsychotics on prolactinaemia: six weeks open-label trial in female in-patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amisulpride; Antipsychotic Agents; Benzodiazepines; Dibenzothiazepines; Dibenzothiepins; Female; Humans; Hyperprolactinemia; Middle Aged; Olanzapine; Prolactin; Prospective Studies; Quetiapine Fumarate; Risperidone; Schizophrenia; Statistics, Nonparametric; Sulpiride | 2007 |
Time course of the changes in antipsychotic-induced hyperprolactinemia following the switch to aripiprazole.
Topics: Adolescent; Adult; Analysis of Variance; Antipsychotic Agents; Aripiprazole; Cross-Over Studies; Drug Therapy, Combination; Female; Humans; Hyperprolactinemia; Middle Aged; Piperazines; Psychiatric Status Rating Scales; Quinolones; Risperidone; Schizophrenia; Severity of Illness Index; Sulpiride; Young Adult | 2008 |
A pilot study of the safety and efficacy of amisulpride and risperidone in elderly psychotic patients.
Topics: Age Factors; Aged; Amisulpride; Antipsychotic Agents; Diagnostic and Statistical Manual of Mental Disorders; Drug Therapy, Combination; Dyspnea; Female; Humans; Intestinal Obstruction; Male; Pilot Projects; Psychiatric Status Rating Scales; Risperidone; Schizophrenia; Schizophrenic Psychology; Sulpiride; Treatment Outcome | 2009 |
Neurocognitive effectiveness of haloperidol, risperidone, and olanzapine in first-episode psychosis: a randomized, controlled 1-year follow-up comparison.
Topics: Adult; Amisulpride; Antipsychotic Agents; Benzodiazepines; Brain; Clozapine; Cognition Disorders; Female; Follow-Up Studies; Haloperidol; Humans; Male; Neuropsychological Tests; Olanzapine; Perphenazine; Piperazines; Prospective Studies; Psychotic Disorders; Risperidone; Severity of Illness Index; Sulpiride; Thiazoles | 2009 |
Long-term efficacy of electroconvulsive therapy combined with different antipsychotic drugs in previously resistant schizophrenia.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Combined Modality Therapy; Dose-Response Relationship, Drug; Drug Resistance; Electroconvulsive Therapy; Female; Follow-Up Studies; Humans; Male; Olanzapine; Prospective Studies; Psychiatric Status Rating Scales; Risperidone; Schizophrenia; Sulpiride; Young Adult | 2009 |
A validation of cognitive biomarkers for the early identification of cognitive enhancing agents in schizotypy: a three-center double-blind placebo-controlled study.
Topics: Adult; Amisulpride; Analysis of Variance; Biomarkers; Cognition Disorders; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Memory, Short-Term; Neuropsychological Tests; Nootropic Agents; Personality Inventory; Reproducibility of Results; Risperidone; Schizotypal Personality Disorder; Sulpiride; Surveys and Questionnaires; United Kingdom; Verbal Behavior; Young Adult | 2012 |
No negative symptoms in healthy volunteers after single doses of amisulpride, aripiprazole, and haloperidol: a double-blind placebo-controlled trial.
Topics: Adult; Amisulpride; Antipsychotic Agents; Aripiprazole; Cognitive Dysfunction; Dizziness; Double-Blind Method; Female; Haloperidol; Humans; Hypnotics and Sedatives; Male; Neurotoxicity Syndromes; Piperazines; Psychiatric Status Rating Scales; Quinolones; Risperidone; Severity of Illness Index; Sulpiride; Time Factors; Young Adult | 2012 |
Cognitive effects of a single dose of atypical antipsychotics in healthy volunteers compared with placebo or haloperidol.
Topics: Adult; Amisulpride; Antipsychotic Agents; Aripiprazole; Cognition; Double-Blind Method; Female; Haloperidol; Humans; Hypnotics and Sedatives; Male; Piperazines; Psychomotor Performance; Quinolones; Risperidone; Sulpiride; Treatment Outcome; Young Adult | 2012 |
Effects of risperidone, amisulpride and nicotine on eye movement control and their modulation by schizotypy.
Topics: Adolescent; Adult; Amisulpride; Antipsychotic Agents; Double-Blind Method; Female; Humans; Male; Nicotine; Psychometrics; Pursuit, Smooth; Risperidone; Saccades; Schizotypal Personality Disorder; Sulpiride; Surveys and Questionnaires; Young Adult | 2013 |
Effectiveness of antipsychotic drugs against hostility in patients with schizophrenia in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) study.
Topics: Adult; Aggression; Amisulpride; Antipsychotic Agents; Benzodiazepines; Female; Haloperidol; Hostility; Humans; Male; Middle Aged; Olanzapine; Perphenazine; Piperazines; Quetiapine Fumarate; Risperidone; Schizophrenia; Schizophrenic Psychology; Sulpiride; Thiazoles | 2014 |
91 other study(ies) available for sulpiride and risperidone
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data.
Topics: Blood Proteins; Chemistry, Physical; Computer Simulation; Humans; Membranes, Artificial; Models, Biological; Pharmaceutical Preparations; Protein Binding; Tissue Distribution | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate.
Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility | 2010 |
Brain tissue binding of drugs: evaluation and validation of solid supported porcine brain membrane vesicles (TRANSIL) as a novel high-throughput method.
Topics: Absorption; Albumins; Animals; Brain; Brain Chemistry; Cell Membrane; Chromatography, High Pressure Liquid; Drug Evaluation, Preclinical; In Vitro Techniques; Lipids; Male; Microdialysis; Pharmaceutical Preparations; Protein Binding; Rats; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Swine; Tissue Distribution | 2011 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
[Study by the intracerebral microdialysis method of the effects of atypical neuroleptics and anxiolytics on striatal release and metabolism of dopamine in awake rats].
Topics: Animals; Anti-Anxiety Agents; Antipsychotic Agents; Brain Chemistry; Buspirone; Corpus Striatum; Dialysis; Dopamine; In Vitro Techniques; Isoxazoles; Male; Methoxydimethyltryptamines; Piperidines; Rats; Rats, Inbred Strains; Risperidone; Ritanserin; Sulpiride; Wakefulness | 1991 |
Effects of typical and atypical antipsychotic drugs on response decrement patterns in rats.
Topics: Animals; Antipsychotic Agents; Clozapine; Conditioning, Operant; Dose-Response Relationship, Drug; Haloperidol; Isoxazoles; Male; Piperidines; Rats; Rats, Wistar; Remoxipride; Risperidone; Serotonin Antagonists; Sulpiride | 1995 |
Antipsychotics with inverse agonist activity at the dopamine D3 receptor.
Topics: Animals; Antipsychotic Agents; Calcium; CHO Cells; Clozapine; Colforsin; Cricetinae; Cyclic AMP; DNA Replication; Dopamine Agonists; Dopamine Antagonists; Dose-Response Relationship, Drug; Flupenthixol; Glioma; Haloperidol; Humans; Hybrid Cells; Naphthalenes; Neuroblastoma; Pertussis Toxin; Phenothiazines; Pimozide; Pyrrolidines; Quinpirole; Receptors, Dopamine D2; Receptors, Dopamine D3; Recombinant Proteins; Risperidone; Salicylamides; Second Messenger Systems; Sulpiride; Tetrahydronaphthalenes; Tumor Cells, Cultured; Virulence Factors, Bordetella | 1996 |
Weight gain: side effect of atypical neuroleptics?
Topics: Adolescent; Adult; Adverse Drug Reaction Reporting Systems; Antipsychotic Agents; Body Mass Index; Clozapine; Delusions; Dibenzothiepins; Female; Humans; Long-Term Care; Male; Middle Aged; Psychotic Disorders; Retrospective Studies; Risperidone; Schizophrenia; Sulpiride; Weight Gain | 1999 |
Pharmacological profile of MS-377, a novel antipsychotic agent with selective affinity for sigma receptors.
Topics: Amisulpride; Animals; Antipsychotic Agents; Apomorphine; Catalepsy; Dopamine Agonists; Free Radical Scavengers; Guinea Pigs; Haloperidol; Head Movements; Male; Mice; Phenazocine; Phencyclidine; Piperazines; Pyrrolidines; Rats; Rats, Wistar; Receptors, Dopamine D2; Receptors, Serotonin; Receptors, sigma; Risperidone; Serotonin; Serotonin Antagonists; Stereotyped Behavior; Sulpiride; Tartrates | 1999 |
[Atypical antipsychotics].
Topics: Acute Disease; Amisulpride; Antipsychotic Agents; Benzodiazepines; Clozapine; Cost-Benefit Analysis; Dibenzothiazepines; Dibenzothiepins; Dyskinesia, Drug-Induced; Germany; Humans; Neurotransmitter Agents; Olanzapine; Patient Compliance; Pirenzepine; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia; Sulpiride | 2000 |
5-HT(2A) and D(2) receptor blockade increases cortical DA release via 5-HT(1A) receptor activation: a possible mechanism of atypical antipsychotic-induced cortical dopamine release.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Amphetamines; Animals; Antipsychotic Agents; Benzodiazepines; Cerebral Cortex; Chromatography, High Pressure Liquid; Dopamine; Dopamine D2 Receptor Antagonists; Male; Microdialysis; Olanzapine; Piperazines; Pirenzepine; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2A; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Risperidone; Selective Serotonin Reuptake Inhibitors; Serotonin Receptor Agonists; Sulpiride | 2001 |
Acute phase of schizophrenia: impact of atypical antipsychotics.
Topics: Acute Disease; Amisulpride; Antipsychotic Agents; Haloperidol; Humans; Prognosis; Recurrence; Risperidone; Schizophrenia; Severity of Illness Index; Sulpiride | 2000 |
In vitro modulation of the firing rate of dopamine neurons in the rat substantia nigra pars compacta and the ventral tegmental area by antipsychotic drugs.
Topics: Action Potentials; Animals; Antipsychotic Agents; Clozapine; Dose-Response Relationship, Drug; Male; Neurons; Rats; Rats, Wistar; Receptors, Dopamine D2; Risperidone; Substantia Nigra; Sulpiride; Ventral Tegmental Area | 2001 |
Atypical neuroleptic drugs downregulate dopamine sensitivity in rat cortical and striatal astrocytes.
Topics: Adrenergic beta-Antagonists; Animals; Animals, Newborn; Antipsychotic Agents; Astrocytes; Benzodiazepines; Calcium; Calcium Signaling; Cells, Cultured; Cerebral Cortex; Clozapine; Dopamine; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Down-Regulation; Haloperidol; Intracellular Fluid; Neostriatum; Olanzapine; Pirenzepine; Rats; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, Dopamine D4; Risperidone; Serotonin Antagonists; Sulpiride | 2001 |
[Incompatibility of olanzapine and amisulpride in multisystemic myotonic myopathy].
Topics: Adult; Amisulpride; Antipsychotic Agents; Benzodiazepines; Creatine Kinase; Drug Interactions; Genetic Predisposition to Disease; Humans; Male; Malignant Hyperthermia; Muscle, Skeletal; Myotonic Disorders; Olanzapine; Pirenzepine; Remission Induction; Risperidone; Schizophrenia; Sulpiride; Treatment Outcome | 2001 |
Atypical, but not typical, antipsychotic drugs increase cortical acetylcholine release without an effect in the nucleus accumbens or striatum.
Topics: Acetylcholine; Acetylcholinesterase; Animals; Antipsychotic Agents; Benzodiazepines; Cerebral Cortex; Cholinesterase Inhibitors; Clozapine; Corpus Striatum; Haloperidol; Male; Nucleus Accumbens; Olanzapine; Oxotremorine; Piperazines; Pirenzepine; Rats; Rats, Sprague-Dawley; Risperidone; Scopolamine; Sulpiride; Thiazoles; Thioridazine | 2002 |
Mechanisms of weight gain induced by antipsychotic drugs.
Topics: Animals; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Appetite; Dopamine Antagonists; Female; Humans; Hypothalamic Area, Lateral; Obesity; Rats; Rats, Wistar; Risperidone; Sex Factors; Sulpiride; Weight Gain | 2002 |
Sub-chronic treatment with classical but not atypical antipsychotics produces morphological changes in rat nigro-striatal dopaminergic neurons directly related to "early onset" vacuous chewing.
Topics: Amisulpride; Animals; Antipsychotic Agents; Clozapine; Dopamine; Dose-Response Relationship, Drug; Drug Administration Schedule; Dyskinesia, Drug-Induced; Haloperidol; Male; Mastication; Neostriatum; Nerve Degeneration; Neural Pathways; Neurons; Rats; Rats, Sprague-Dawley; Risperidone; Substance Withdrawal Syndrome; Substantia Nigra; Sulpiride | 2002 |
Effects of atypical antipsychotics on vertebrate neuromuscular transmission.
Topics: Animals; Antipsychotic Agents; Benzodiazepines; Clozapine; Fluphenazine; In Vitro Techniques; Membrane Potentials; Motor Endplate; Neuromuscular Junction; Olanzapine; Pirenzepine; Rana pipiens; Rana temporaria; Risperidone; Sulpiride; Synaptic Transmission | 2002 |
Neuroleptic malignant syndrome due to atypical neuroleptics: three episodes in one patient.
Topics: Amisulpride; Antipsychotic Agents; Clozapine; Female; Humans; Middle Aged; Neuroleptic Malignant Syndrome; Risperidone; Schizophrenia; Sulpiride | 2002 |
Amisulpride improves depressive symptoms in acute exacerbations of schizophrenia: comparison with haloperidol and risperidone.
Topics: Adult; Amisulpride; Antipsychotic Agents; Brief Psychiatric Rating Scale; Depression; Double-Blind Method; Female; Haloperidol; Humans; Male; Middle Aged; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia; Sulpiride; Treatment Outcome | 2002 |
Comparative effects of the antipsychotics sulpiride or risperidone in rats. I: bodyweight, food intake, body composition, hormones and glucose tolerance.
Topics: Animals; Antipsychotic Agents; Blood Glucose; Body Composition; Body Weight; Corticosterone; Eating; Estradiol; Female; Glucose Tolerance Test; Hormones; Male; Progesterone; Prolactin; Radioimmunoassay; Rats; Rats, Wistar; Risperidone; Sex Characteristics; Sulpiride; Time Factors | 2002 |
Discriminative stimulus properties in rats of the novel antipsychotic quetiapine.
Topics: Amisulpride; Analysis of Variance; Animals; Antipsychotic Agents; Chlorpromazine; Clozapine; Dibenzothiazepines; Discrimination Learning; Discrimination, Psychological; Dose-Response Relationship, Drug; Female; Generalization, Psychological; Haloperidol; Loxapine; Quetiapine Fumarate; Quinoxalines; Rats; Rats, Wistar; Risperidone; Sulpiride | 2002 |
[Plasma prolactin level and incidence of adverse endocrinologic effects during therapy with atypical neuroleptics].
Topics: Adult; Amisulpride; Antipsychotic Agents; Benzodiazepines; Depressive Disorder, Major; Dibenzothiazepines; Female; Humans; Hyperprolactinemia; Male; Middle Aged; Olanzapine; Pirenzepine; Product Surveillance, Postmarketing; Prolactin; Psychotic Disorders; Quetiapine Fumarate; Risperidone; Schizophrenia; Sulpiride | 2003 |
[Psychotropic drugs used in a psychiatric hospital (pharmaco-epidemiologic aspects)].
Topics: Antidepressive Agents; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Benzodiazepines; Carbazoles; Chlorprothixene; Clopenthixol; Data Collection; Dopamine Antagonists; Female; Fluoxetine; Flupenthixol; Hospitals, Psychiatric; Humans; Male; Mental Disorders; Mianserin; Middle Aged; Mirtazapine; Monoamine Oxidase Inhibitors; Moscow; Nootropic Agents; Olanzapine; Pharmacoepidemiology; Phenothiazines; Psychotropic Drugs; Risperidone; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Sulpiride | 2003 |
Serotonin reuptake inhibitor provoked recurrence of alcohol hallucinosis--remission with additive amisulpride medication. A case report.
Topics: Alcohol Withdrawal Delirium; Amisulpride; Antipsychotic Agents; Drug Therapy, Combination; Humans; Male; Middle Aged; Recurrence; Risperidone; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Sertraline; Sulpiride | 2004 |
Effects of amisulpride, risperidone and chlorpromazine on auditory and visual latent inhibition, prepulse inhibition, executive function and eye movements in healthy volunteers.
Topics: Acoustic Stimulation; Administration, Oral; Adult; Akathisia, Drug-Induced; Amisulpride; Blood Pressure; Chlorpromazine; Controlled Clinical Trials as Topic; Demography; Double-Blind Method; Eye Movements; Humans; Male; Neuropsychological Tests; Photic Stimulation; Problem Solving; Reaction Time; Reflex, Startle; Risperidone; Space Perception; Sulpiride; Verbal Behavior | 2004 |
[Rehospitalization rates of newly diagnosed schizophrenic patients on atypical neuroleptic medication].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amisulpride; Antipsychotic Agents; Benzodiazepines; Female; Follow-Up Studies; Germany; Humans; Long-Term Care; Male; Middle Aged; Olanzapine; Patient Readmission; Retrospective Studies; Risperidone; Schizophrenia; Schizophrenic Psychology; Sulpiride; Treatment Outcome; Treatment Refusal | 2004 |
Comparative effects of the antipsychotics sulpiride and risperidone in female rats on energy balance, body composition, fat morphology and macronutrient selection.
Topics: Adipocytes; Adipose Tissue; Animals; Antipsychotic Agents; Body Composition; Body Weight; Cell Count; Corticosterone; Dietary Fats; Eating; Energy Metabolism; Female; Leptin; Prolactin; Proteins; Rats; Rats, Wistar; Risperidone; Sulpiride | 2004 |
The impact of neuroleptic medication on seizure threshold and duration in electroconvulsive therapy.
Topics: Adult; Aged; Antipsychotic Agents; Benzodiazepines; Brain; Clopenthixol; Clozapine; Dibenzothiazepines; Electric Impedance; Electroconvulsive Therapy; Electroencephalography; Electromyography; Female; Fluphenazine; Haloperidol; Humans; Male; Middle Aged; Olanzapine; Quetiapine Fumarate; Risperidone; Seizures; Sulpiride | 2004 |
Atypical anti-psychotics in the real world--a naturalistic comparative outcome study.
Topics: Adolescent; Adult; Aged; Amisulpride; Antipsychotic Agents; Benzodiazepines; Clozapine; Dibenzothiazepines; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Male; Middle Aged; Olanzapine; Patient Compliance; Probability; Prospective Studies; Psychiatric Status Rating Scales; Psychotic Disorders; Quality of Life; Quetiapine Fumarate; Risk Assessment; Risperidone; Severity of Illness Index; Statistics, Nonparametric; Sulpiride; Treatment Outcome | 2005 |
Prototypical antipsychotic drugs protect hippocampal neuronal cultures against cell death induced by growth medium deprivation.
Topics: Animals; Anisoles; Antipsychotic Agents; Benzazepines; Butaclamol; Caspase Inhibitors; Cell Death; Cells, Cultured; Chlorpromazine; Clozapine; Domperidone; Dopamine Antagonists; Excitatory Amino Acid Antagonists; Ginkgo biloba; Haloperidol; Hippocampus; Indans; Isoxazoles; Neurons; Neuroprotective Agents; Peptides; Piperidines; Plant Extracts; Propylamines; Raclopride; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Receptors, N-Methyl-D-Aspartate; Remoxipride; Risperidone; Sulpiride | 2006 |
Remission and relapse in the outpatient care of schizophrenia: three-year results from the Schizophrenia Outpatient Health Outcomes study.
Topics: Adult; Ambulatory Care; Amisulpride; Antipsychotic Agents; Benzodiazepines; Clozapine; Cohort Studies; Dibenzothiazepines; Europe; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Logistic Models; Male; Olanzapine; Prospective Studies; Quetiapine Fumarate; Recurrence; Risk Factors; Risperidone; Schizophrenia; Sulpiride; Time Factors; Treatment Outcome | 2006 |
Lack of enhanced effect of antipsychotics combined with fluvoxamine on acetylcholine release in rat prefrontal cortex.
Topics: Acetylcholine; Animals; Antipsychotic Agents; Depression; Drug Interactions; Drug Therapy, Combination; Fluvoxamine; Loxapine; Male; Microdialysis; Prefrontal Cortex; Rats; Rats, Wistar; Risperidone; Selective Serotonin Reuptake Inhibitors; Sulpiride; Time Factors | 2006 |
Atypical antipsychotics and pituitary neoplasms in the WHO database.
Topics: Adenoma; Adult; Adverse Drug Reaction Reporting Systems; Amisulpride; Antipsychotic Agents; Causality; Female; Humans; Male; Pituitary Neoplasms; Risk; Risperidone; Schizophrenia; Sulpiride; World Health Organization | 2007 |
Do differences in atypical antipsychotics matter in routine practice? Medication switch from olanzapine and risperidone to amisulpride.
Topics: Adolescent; Adult; Amisulpride; Antipsychotic Agents; Benzodiazepines; Drug Utilization; Dyskinesia, Drug-Induced; Female; Germany; Humans; Male; Middle Aged; Olanzapine; Risperidone; Schizophrenia; Schizophrenic Psychology; Structure-Activity Relationship; Sulpiride; Weight Gain | 2007 |
Atypical antipsychotic therapy for treatment of schizophrenia in Hong Kong Chinese patients--a cost analysis.
Topics: Adult; Amisulpride; Antipsychotic Agents; Benzodiazepines; China; Cost of Illness; Cost-Benefit Analysis; Databases, Factual; Delayed-Action Preparations; Dibenzothiazepines; Female; Health Care Costs; Hong Kong; Hospitalization; Humans; Male; Medical Records; Middle Aged; Olanzapine; Quetiapine Fumarate; Regression Analysis; Retrospective Studies; Risperidone; Schizophrenia; Substance-Related Disorders; Sulpiride | 2007 |
The influence of clozapine treatment and other antipsychotics on the 18 kDa translocator protein, formerly named the peripheral-type benzodiazepine receptor, and steroid production.
Topics: Adrenal Glands; Animals; Antipsychotic Agents; Brain; Cell Line; Clozapine; Corticosterone; Humans; Isoquinolines; Male; Mice; Mitochondria; Radioimmunoassay; Rats; Rats, Sprague-Dawley; Receptors, GABA; Risperidone; Steroids; Sulpiride; Testis; Testosterone; Thioridazine | 2008 |
Prevalence of hyperprolactinaemia in a naturalistic cohort of schizophrenia and bipolar outpatients during treatment with typical and atypical antipsychotics.
Topics: Adult; Amisulpride; Antipsychotic Agents; Bipolar Disorder; Cohort Studies; Cross-Sectional Studies; England; Female; Humans; Hyperprolactinemia; Male; Mass Screening; Middle Aged; Prevalence; Prolactin; Risperidone; Schizophrenia; Severity of Illness Index; Sex Factors; Sulpiride | 2007 |
The use of atypical antipsychotics in French psychiatric hospitals.
Topics: Adult; Age Factors; Amisulpride; Antimanic Agents; Antiparkinson Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Clozapine; Cross-Sectional Studies; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; France; Hospitals, Psychiatric; Humans; Male; Mental Disorders; Middle Aged; Olanzapine; Practice Patterns, Physicians'; Psychotic Disorders; Risperidone; Sex Factors; Sulpiride | 2007 |
Atypical antipsychotic drugs in the treatment of delusional parasitosis.
Topics: Adolescent; Adult; Aged; Amisulpride; Antipsychotic Agents; Benzodiazepines; Female; Follow-Up Studies; Humans; Injections; Male; Middle Aged; Myocardial Infarction; Olanzapine; Parasitic Diseases; Paresthesia; Patient Compliance; Risperidone; Schizophrenia, Paranoid; Somatoform Disorders; Sulpiride; Treatment Outcome | 2007 |
Distinct neurobehavioral consequences of prenatal exposure to sulpiride (SUL) and risperidone (RIS) in rats.
Topics: Animals; Antipsychotic Agents; Behavior, Animal; Body Weight; Brain; Conditioning, Psychological; Disease Models, Animal; Dopamine Antagonists; Exploratory Behavior; Female; Growth; Male; Maternal Exposure; Maze Learning; Memory; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Sprague-Dawley; Receptors, Dopamine; Receptors, Serotonin; Risperidone; Sulpiride | 2008 |
Comparing the use and discontinuation of antipsychotics in clinical practice: an observational study.
Topics: Adult; Aged; Amisulpride; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Clozapine; Dibenzothiazepines; Drug Administration Schedule; Female; Humans; Male; Medical Records; Middle Aged; Olanzapine; Patient Admission; Polypharmacy; Practice Patterns, Physicians'; Quetiapine Fumarate; Research Design; Retrospective Studies; Risperidone; Schizophrenia; Scotland; Sulpiride | 2008 |
Amisulpride improves obsessive-compulsive symptoms in schizophrenia patients taking atypical antipsychotics: an open-label switch study.
Topics: Adult; Amisulpride; Antipsychotic Agents; Aripiprazole; Comorbidity; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Obsessive-Compulsive Disorder; Piperazines; Prospective Studies; Psychiatric Status Rating Scales; Quinolones; Risperidone; Schizophrenia; Schizophrenic Psychology; Sulpiride; Treatment Outcome | 2008 |
Amisulpride the 'atypical' atypical antipsychotic--comparison to haloperidol, risperidone and clozapine.
Topics: Amisulpride; Amphetamine; Animals; Antipsychotic Agents; Basal Ganglia; Behavior, Animal; Blood-Brain Barrier; Brain; Clozapine; Conditioning, Psychological; Haloperidol; Male; Models, Animal; Motor Activity; Phencyclidine; Prefrontal Cortex; Prolactin; Rats; Rats, Sprague-Dawley; Receptors, Dopamine; Receptors, Dopamine D2; Receptors, Dopamine D3; Receptors, Serotonin; Risperidone; Sulpiride | 2008 |
Antipsychotics possessing antidepressive efficacy increase Golf protein in rat striatum.
Topics: Amisulpride; Animals; Antipsychotic Agents; Benzodiazepines; Blotting, Western; Clozapine; Corpus Striatum; Depressive Disorder; Dose-Response Relationship, Drug; GTP-Binding Protein alpha Subunits; Haloperidol; Injections, Intraperitoneal; Male; Olanzapine; Rats; Rats, Wistar; Risperidone; Sulpiride; Time Factors | 2008 |
Is second-generation antipsychotic-induced hyperprolactinemia due to biologically active prolactin or to biologically inactive macroprolactin? Results from a prospective study.
Topics: Adolescent; Adult; Amisulpride; Antipsychotic Agents; Diagnosis, Differential; Female; Humans; Hyperprolactinemia; Male; Middle Aged; Prolactin; Prospective Studies; Risk Factors; Risperidone; Schizophrenia; Sulpiride; Young Adult | 2009 |
Neuroleptics: necrotising enterocolitis.
Topics: Antipsychotic Agents; Atropine; Benzodiazepines; Clozapine; Drug Therapy, Combination; Enterocolitis, Necrotizing; France; Humans; Risperidone; Sulpiride | 2009 |
Reduced serum BDNF levels in patients with chronic schizophrenic disorder in relapse, who were treated with typical or atypical antipsychotics.
Topics: Adult; Amisulpride; Antipsychotic Agents; Benzodiazepines; Brain-Derived Neurotrophic Factor; Case-Control Studies; Female; Haloperidol; Humans; Male; Middle Aged; Olanzapine; Risperidone; Schizophrenia; Sulpiride; Treatment Failure | 2010 |
Haloperidol induces higher Homer1a expression than risperidone, olanzapine and sulpiride in striatal sub-regions.
Topics: Animals; Antipsychotic Agents; Benzodiazepines; Brain Mapping; Carrier Proteins; Corpus Striatum; Gene Expression Regulation; Haloperidol; Homer Scaffolding Proteins; Male; Olanzapine; Random Allocation; Rats; Rats, Sprague-Dawley; Risperidone; RNA, Messenger; Sulpiride | 2010 |
Amenorrhoea - consequence of combined treatment with sulpiride and risperidone in a patient suffering from schizophrenia.
Topics: Amenorrhea; Antipsychotic Agents; Drug Therapy, Combination; Female; Humans; Hyperprolactinemia; Middle Aged; Prolactin; Risperidone; Schizophrenia; Schizophrenia, Catatonic; Sulpiride | 2010 |
Positron emission tomography measurement of dopamine D₂ receptor occupancy in the pituitary and cerebral cortex: relation to antipsychotic-induced hyperprolactinemia.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Carbon Radioisotopes; Cerebellar Cortex; Cerebral Cortex; Computer Graphics; Dopamine Antagonists; Dose-Response Relationship, Drug; Haloperidol; Humans; Hyperprolactinemia; Male; Mathematical Computing; Middle Aged; Olanzapine; Pituitary Gland; Positron-Emission Tomography; Prolactin; Pyrrolidines; Receptors, Dopamine D2; Risperidone; Salicylamides; Schizophrenia; Statistics as Topic; Sulpiride; Temporal Lobe; Young Adult | 2010 |
Serotonin-dopamine antagonism ameliorates impairments of spontaneous alternation and locomotor hyperactivity induced by repeated electroconvulsive seizures in rats.
Topics: Analysis of Variance; Animals; Behavior, Animal; Dopamine Antagonists; Electroshock; Haloperidol; Hyperkinesis; Ketanserin; Male; Motor Activity; Random Allocation; Rats; Rats, Wistar; Receptors, Dopamine D2; Receptors, Serotonin, 5-HT2; Risperidone; Seizures; Serotonin Antagonists; Sulpiride | 2010 |
Clock genes and body composition in patients with schizophrenia under treatment with antipsychotic drugs.
Topics: Adult; Age Factors; Alleles; Amisulpride; Anthropometry; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Body Composition; Body Mass Index; CLOCK Proteins; Clozapine; Dibenzothiazepines; Drug Therapy, Combination; Female; Genetic Association Studies; Genetic Carrier Screening; Genotype; Humans; Long-Term Care; Male; Middle Aged; Mutation, Missense; Olanzapine; Period Circadian Proteins; Piperazines; Polymorphism, Single Nucleotide; Psychotic Disorders; Quetiapine Fumarate; Quinolones; Receptor, Melanocortin, Type 3; Receptors, Glucocorticoid; Receptors, Leptin; Risperidone; Schizophrenia; Sex Factors; Sulpiride; Syndecan-3 | 2011 |
Gastroprotective potential of risperidone, an atypical antipsychotic, against stress and pyloric ligation induced gastric lesions.
Topics: Animals; Antipsychotic Agents; Capillary Permeability; Dinoprostone; Disease Models, Animal; Dopamine D2 Receptor Antagonists; Glyburide; Hexosamines; Indomethacin; KATP Channels; Ketanserin; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Rats; Receptors, Dopamine D2; Receptors, Serotonin, 5-HT2; Risperidone; Stomach Ulcer; Stress, Physiological; Sulfhydryl Compounds; Sulpiride | 2011 |
Onset of action of atypical and typical antipsychotics in the treatment of adolescent schizophrenic psychoses.
Topics: Adolescent; Antipsychotic Agents; Benzodiazepines; Clozapine; Dibenzothiazepines; Female; Haloperidol; Humans; Male; Medical Records; Olanzapine; Perphenazine; Piperazines; Psychotic Disorders; Quetiapine Fumarate; Risperidone; Schizophrenia; Sulpiride; Thiazoles; Time Factors; Treatment Outcome | 2011 |
Treatment practices in Tourette syndrome: the European perspective.
Topics: Adult; Antidepressive Agents; Antipsychotic Agents; Anxiety; Aripiprazole; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Clonidine; Depression; Europe; Fluoxetine; Fluvoxamine; Health Care Surveys; Humans; Methylphenidate; Obsessive-Compulsive Disorder; Physicians; Piperazines; Propylamines; Psychiatry; Quinolones; Risperidone; Sertraline; Sulpiride; Tourette Syndrome | 2012 |
Attentional and emotional functioning in schizophrenia patients treated with conventional and atypical antipsychotic drugs.
Topics: Adult; Amisulpride; Analysis of Variance; Antipsychotic Agents; Attention; Benzodiazepines; Dibenzothiazepines; Emotions; Fluphenazine; Haloperidol; Humans; Memory; Middle Aged; Olanzapine; Perazine; Perphenazine; Quetiapine Fumarate; Recognition, Psychology; Risperidone; Schizophrenia; Sulpiride | 2012 |
Second-generation antipsychotic medications and risk of pneumonia in schizophrenia.
Topics: Adult; Amisulpride; Antipsychotic Agents; Benzodiazepines; Case-Control Studies; Clozapine; Cohort Studies; Dibenzothiazepines; Dibenzothiepins; Drug Therapy, Combination; Female; Humans; Logistic Models; Male; Middle Aged; Olanzapine; Pneumonia; Quetiapine Fumarate; Risk Factors; Risperidone; Schizophrenia; Sulpiride; Taiwan | 2013 |
Effectiveness of sulpiride in adult patients with schizophrenia.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Benzodiazepines; Cohort Studies; Female; Haloperidol; Humans; Male; Middle Aged; Olanzapine; Proportional Hazards Models; Retrospective Studies; Risperidone; Schizophrenia; Sulpiride; Treatment Outcome; Young Adult | 2013 |
Changes in sexual function and gonadal axis hormones after switching to aripiprazole in male schizophrenia patients: a prospective pilot study.
Topics: Adult; Amisulpride; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Estradiol; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Male; Middle Aged; Olanzapine; Pilot Projects; Piperazines; Prolactin; Prospective Studies; Quinolones; Retreatment; Risperidone; Schizophrenia; Sex Hormone-Binding Globulin; Sexual Dysfunction, Physiological; Sexual Dysfunctions, Psychological; Sulpiride; Testosterone | 2012 |
Effects of drop-out on efficacy estimates in five Cochrane reviews of popular antipsychotics for schizophrenia.
Topics: Amisulpride; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Data Interpretation, Statistical; Dibenzothiazepines; Humans; Olanzapine; Patient Dropouts; Piperazines; Quetiapine Fumarate; Quinolones; Review Literature as Topic; Risperidone; Schizophrenia; Sulpiride | 2012 |
Antipsychotic monotherapy and polypharmacy in the treatment of outpatients with schizophrenia in the European Schizophrenia Outpatient Health Outcomes Study.
Topics: Adult; Amisulpride; Antipsychotic Agents; Benzodiazepines; Dibenzothiazepines; Europe; Female; Humans; Logistic Models; Male; Olanzapine; Polypharmacy; Prospective Studies; Quetiapine Fumarate; Risperidone; Schizophrenia; Sulpiride; Time Factors | 2012 |
Risperidone augmentation with amisulpride: the blue-tongue sign.
Topics: Amisulpride; Dopamine Antagonists; Drug Therapy, Combination; Humans; Male; Melanins; Pigmentation; Risperidone; Schizophrenia; Sulpiride; Tongue; Young Adult | 2012 |
Choline acetyltransferase expression in rat prefrontal cortex and hippocampus after acute and chronic exposure to amisulpride, haloperidol, and risperidone.
Topics: Amisulpride; Animals; Antipsychotic Agents; Choline O-Acetyltransferase; Dose-Response Relationship, Drug; Haloperidol; Hippocampus; Male; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Risperidone; Sulpiride; Time Factors | 2012 |
Mismatch negativity and cognitive performance for the prediction of psychosis in subjects with at-risk mental state.
Topics: Adolescent; Adult; Antipsychotic Agents; Aripiprazole; Cognition Disorders; Electroencephalography; Evoked Potentials; Female; Humans; Male; Middle Aged; Neuropsychological Tests; Piperazines; Psychotic Disorders; Quinolones; Risk Factors; Risperidone; Schizophrenia; Schizophrenic Psychology; Sulpiride; Young Adult | 2013 |
White-matter microstructure in previously drug-naive patients with schizophrenia after 6 weeks of treatment.
Topics: Adolescent; Adult; Anisotropy; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Brain; Brain Mapping; Case-Control Studies; Dibenzothiazepines; Diffusion Tensor Imaging; Female; Frontal Lobe; Gyrus Cinguli; Haloperidol; Humans; Image Processing, Computer-Assisted; Male; Nerve Fibers, Myelinated; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Risperidone; Schizophrenia; Schizophrenic Psychology; Sulpiride; Treatment Outcome; Young Adult | 2013 |
Delusional infestation: a clinical profile.
Topics: Adult; Amisulpride; Antipsychotic Agents; Benzodiazepines; Delusions; Ectoparasitic Infestations; Female; Humans; Male; Middle Aged; Olanzapine; Risperidone; Sulpiride; Treatment Outcome | 2013 |
LC-MS/MS of some atypical antipsychotics in human plasma, serum, oral fluid and haemolysed whole blood.
Topics: Amisulpride; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Chromatography, Liquid; Clozapine; Dibenzothiazepines; Female; Forensic Toxicology; Hemolysis; Humans; Isoxazoles; Male; Olanzapine; Paliperidone Palmitate; Piperazines; Pyrimidines; Quetiapine Fumarate; Quinolones; Reproducibility of Results; Risperidone; Saliva; Serum; Sulpiride; Tandem Mass Spectrometry | 2013 |
Stability of some atypical antipsychotics in human plasma, haemolysed whole blood, oral fluid, human serum and calf serum.
Topics: Amisulpride; Animals; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Cattle; Chromatography, Liquid; Clozapine; Dibenzothiazepines; Drug Stability; Female; Forensic Toxicology; Hemolysis; Humans; Isoxazoles; Male; Olanzapine; Paliperidone Palmitate; Piperazines; Pyrimidines; Quetiapine Fumarate; Quinolones; Reproducibility of Results; Risperidone; Saliva; Serum; Sulpiride; Tandem Mass Spectrometry | 2013 |
Effects of cabergoline on hyperprolactinemia, psychopathology, and sexual functioning in schizophrenic patients.
Topics: Adult; Amisulpride; Antipsychotic Agents; Cabergoline; Diagnostic and Statistical Manual of Mental Disorders; Dopamine Agonists; Dose-Response Relationship, Drug; Ergolines; Female; Haloperidol; Humans; Hyperprolactinemia; Longitudinal Studies; Maintenance Chemotherapy; Male; Middle Aged; Prolactin; Prospective Studies; Risperidone; Schizophrenia; Schizophrenic Psychology; Severity of Illness Index; Sexual Dysfunction, Physiological; Sulpiride | 2013 |
Hypochondriasis and obsessive-compulsive disorder in schizophrenic patients treated with clozapine vs other atypical antipsychotics.
Topics: Adult; Amisulpride; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clozapine; Comorbidity; Female; Humans; Hypochondriasis; Male; Middle Aged; Obsessive-Compulsive Disorder; Olanzapine; Paliperidone Palmitate; Prevalence; Quetiapine Fumarate; Risperidone; Schizophrenia; Schizophrenic Psychology; Sulpiride | 2014 |
Influence of aripiprazole, risperidone, and amisulpride on sensory and sensorimotor gating in healthy 'low and high gating' humans and relation to psychometry.
Topics: Acoustic Stimulation; Amisulpride; Antipsychotic Agents; Aripiprazole; Auditory Perception; Benzhydryl Compounds; Brain; Double-Blind Method; Electroencephalography; Electromyography; Humans; Lorazepam; Male; Modafinil; Piperazines; Prepulse Inhibition; Psychometrics; Psychotropic Drugs; Quinolones; Risperidone; Sensory Gating; Sulpiride; Valproic Acid; Young Adult | 2014 |
The relief of leukocytopenia within 1 month after switching risperidone to amisulpride.
Topics: Amisulpride; Antipsychotic Agents; Drug Substitution; Humans; Leukopenia; Male; Risperidone; Sulpiride; Young Adult | 2014 |
Augmentation with amisulpride for schizophrenic patients non-responsive to risperidone monotherapy.
Topics: Administration, Oral; Adult; Aged; Amisulpride; Antipsychotic Agents; Drug Therapy, Combination; Female; Humans; Injections, Intramuscular; Male; Middle Aged; Psychiatric Status Rating Scales; Risperidone; Schizophrenia; Sulpiride; Young Adult | 2015 |
Amisulpride-associated mania in a young adult with schizophrenia and cerebral disease.
Topics: Amisulpride; Antipsychotic Agents; Bipolar Disorder; Cerebral Palsy; Drug Administration Schedule; Humans; Male; Risperidone; Schizophrenia; Sulpiride; Taiwan; Young Adult | 2014 |
Dosage and duration of antipsychotic treatment in demented outpatients with agitation or psychosis.
Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Dementia; Female; Humans; Male; Middle Aged; Outpatients; Psychomotor Agitation; Quetiapine Fumarate; Retrospective Studies; Risperidone; Severity of Illness Index; Sulpiride; Taiwan; Treatment Outcome | 2015 |
Level of serum thioredoxin and correlation with neurocognitive functions in patients with schizophrenia using clozapine and other atypical antipsychotics.
Topics: Adult; Amisulpride; Antipsychotic Agents; Benzodiazepines; Clozapine; Cognition; Female; Humans; Male; Middle Aged; Neuropsychological Tests; Olanzapine; Psychotic Disorders; Risperidone; Schizophrenia; Sulpiride; Thioredoxins; Young Adult | 2017 |
Comparison of the effectiveness of brand-name and generic antipsychotic drugs for treating patients with schizophrenia in Taiwan.
Topics: Adult; Antipsychotic Agents; Cohort Studies; Drug Utilization Review; Drugs, Generic; Female; Humans; Male; Middle Aged; National Health Programs; Risperidone; Schizophrenia; Statistics, Nonparametric; Sulpiride; Taiwan; Treatment Outcome | 2018 |
Risperidone and sulpiride: Brands vs generics.
Topics: Antipsychotic Agents; Drugs, Generic; Female; Humans; Male; Risperidone; Schizophrenia; Sulpiride | 2018 |
Response to "Risperidone and sulpiride: Brands vs generics".
Topics: Antipsychotic Agents; Drugs, Generic; Humans; Mental Disorders; Risperidone; Sulpiride | 2018 |
[Aripiprazole for drug-induced sexual dysfunction in schizophrenic males].
Topics: Amisulpride; Antipsychotic Agents; Aripiprazole; Drug Administration Schedule; Humans; Male; Prolactin; Risperidone; Schizophrenia; Sexual Behavior; Sexual Dysfunction, Physiological; Sulpiride; Testosterone; Treatment Outcome | 2017 |
Antipsychotics and pituitary tumors: an analysis of the European pharmacovigilance database (EudraVigilance).
Topics: Adolescent; Adult; Aged; Amisulpride; Antipsychotic Agents; Child; Databases, Factual; Female; Haloperidol; Humans; Male; Middle Aged; Olanzapine; Paliperidone Palmitate; Pharmacovigilance; Pituitary Neoplasms; Pregnancy; Quetiapine Fumarate; Retrospective Studies; Risperidone; Sulpiride; Young Adult | 2019 |
Identification and Quantification of Antipsychotics in Blood Samples by LC-MS-MS: Case Reports and Data from Three Years of Routine Analysis.
Topics: Adult; Amisulpride; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Chromatography, Liquid; Clozapine; Dibenzothiazepines; Female; Forensic Toxicology; Humans; Male; Olanzapine; Paliperidone Palmitate; Piperazines; Quetiapine Fumarate; Retrospective Studies; Risperidone; Schizophrenia; Substance Abuse Detection; Suicide; Sulpiride; Tandem Mass Spectrometry; Thiazoles | 2020 |
Letter to the Editor: Rethinking The Cost Of Antipsychotic Treatment: The Average Cost Of The Drugs Used In Turkey In 2020.
Topics: Adenosine Monophosphate; Adult; Amisulpride; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Chlorpromazine; Clopenthixol; Clozapine; Flupenthixol; Fluphenazine; Haloperidol; Humans; Olanzapine; Paliperidone Palmitate; Pharmaceutical Preparations; Pimozide; Quetiapine Fumarate; Risperidone; Sulpiride; Trifluoperazine | 2022 |
Effect of risperidone on morphine-induced conditioned place preference and dopamine receptor D2 gene expression in male rat hippocampus.
Topics: Animals; Dose-Response Relationship, Drug; Gene Expression; Hippocampus; Male; Morphine; Rats; Rats, Wistar; Receptors, Dopamine D1; Risperidone; Sulpiride | 2023 |